Adkins EM, Nicholson L, Floyd D, Ratcliffe M, & Chevrou-Severac H. (2017). Oncology drugs for orphan indications: How are HTA processes evolving for this specific drug category? Dove Medical Press.
Chicago Style (17th ed.) CitationAdkins EM, Nicholson L, Floyd D, Ratcliffe M, and Chevrou-Severac H. Oncology Drugs for Orphan Indications: How Are HTA Processes Evolving for This Specific Drug Category? Dove Medical Press, 2017.
MLA (9th ed.) CitationAdkins EM, et al. Oncology Drugs for Orphan Indications: How Are HTA Processes Evolving for This Specific Drug Category? Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.